Nicole Friedland, chief executive of the National Alopecia Areata Foundation (NAAF) in the US, said that Olumiant's approval is "a milestone [that] can spark hope for many patients and encourage ...

The cause of the condition is unknown and it impacts as many as 6.7 million people in the United States alone, the National Alopecia Areata Foundation reports. In the footage shared to social ...

Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...

HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

Lili Reinhart is giving an "honest glimpse" into her search for answers related to her health in a detailed recap of what she ...

communications director at the National Alopecia Areata Foundation. Rio Allred, a 12-year-old girl with the disorder, took her own life after being bullied at school in Indiana. Her mother ...

An increase in healthcare spending is being driven by an increase in the number of initiatives being undertaken by organizations such as the National Alopecia Treatment Areata Foundation and the ...

According to the National Alopecia Areata Foundation, the condition affects both children and adults. Latimer says everyone’s experience with alopecia is different, with symptoms appearing at ...

Alopecia areata causes hair loss on the scalp or other body parts such as the eyebrows. New treatments like Olumiant offer hope for some people. This FDA-approved medicine works in unique ways to ...

Globally, the disease impacts about 160 million, according to the National Alopecia Areata Foundation. “It has impacted me both positively and negatively. Sometimes it’s really hard to be ...